查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区新生儿筛检市场预测至 2030 年 - 区域分析 - 按产品类型（试剂和检测试剂盒及仪器）、技术、测试类型和最终用户（医院和诊所以及诊断实验室）
市场调查报告书
商品编码
1463687

亚太地区新生儿筛检市场预测至 2030 年 - 区域分析 - 按产品类型（试剂和检测试剂盒及仪器）、技术、测试类型和最终用户（医院和诊所以及诊断实验室）

Asia Pacific Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日期: | 出版商: The Insight Partners | 英文 107 Pages | 订单完成后即时交付

价格

2022年亚太新生儿筛检市场价值为2.7013亿美元，预计到2030年将达到6.0214亿美元；预计2022年至2030年CAGR为10.5%。

新生儿基因筛检推动亚太新生儿筛检市场的发展。

随着人们对疾病遗传原因的认识不断加深以及医疗保健技术的进步，对新生儿进行全面基因筛检的需求正在增加。因此，新生儿筛检市场的公司正在开发创新、经济高效的筛检解决方案。 Yescarta 和 Zynteglo 是针对大 B 细胞淋巴瘤和 β 地中海贫血的授权基因治疗的两个例子。此外，技术的出现赋予了识别出生时疾病遗传倾向的能力，为个人化医疗保健铺平了道路，与精准医疗的更广泛趋势保持一致。

孕期遗传疾病筛检的重点还在于及早发现与妊娠相关的问题。新一代定序有助于新生儿产前筛检，检测所有染色体的非整倍体（如唐氏症和 21 三体性）或部分染色体异常（重复或缺失）的敏感度超过 95%。萤光原位杂交（FISH）用于检测镰状细胞性贫血等单基因疾病；它还有助于有效的植入前遗传学诊断。使用母体血浆进行无细胞胎儿 DNA 等非侵入性操作是基因检测的最新进展。胚胎 DNA 可以根据大小差异与母体 DNA 片段区分开来。使用萤光探针的即时 PCR、鸟枪定序（Solexa 或 Illumina）或大规模标靶平行定序可用于检查与胎儿健康状况相关的 DNA。如果进一步研究这种类型的基因筛检，这将使医生能够透过某些药物疗法（药物遗传学）提供早期分子干预，并在物理和化学上改造细胞、组织和器官。因此，婴儿遗传性疾病筛检方法的进步为整个新生儿筛检市场带来了巨大的潜力。

亚太地区新生儿筛检市场概况

亚太地区的新生儿筛检市场分为中国、日本、印度、韩国、澳洲和亚太其他地区。亚太地区新生儿筛检市场分为日本、中国、印度、韩国、澳洲和亚太其他地区。预计亚太地区将成为 2022-2030 年全球新生儿筛检市场成长最快的地区。该地区市场的预期成长可能与新生儿出生数量高、先天性疾病盛行率飙升、对新生儿出生缺陷早期诊断的认识不断提高以及致力于为新生儿提供更好解决方案的组织的存在有关。筛选。

亚太地区新生儿筛检日益受到关注；由于出生率高，中国、印度等国家的政府机构需要实施新生儿筛检计画。根据联合国国际儿童紧急基金会（UNICEF）的数据，印度每天有 67,385 名婴儿出生，占全球单日分娩人数的六分之一。此外，印度已成为人口最多的国家；根据 Worldmapper 的数据，2022 年约有 2,300 万名婴儿出生，其次是中国，出生人数为 1,000 万人。随着出生率的不断飙升，印度以及亚太地区其他国家对婴儿照护的关注日益增加。

亚太地区新生儿筛检市场收入及 2030 年预测（百万美元）

亚太地区新生儿筛检市场细分

亚太地区新生儿筛检市场根据产品类型、技术、测试类型、最终用户和国家进行细分。

根据产品类型，亚太地区新生儿筛检市场分为试剂、检测试剂盒和仪器。到 2022 年，试剂和检测试剂盒细分市场将占据更大的亚太新生儿筛检市场份额。仪器部分细分为新生儿疾病筛检仪器、脉搏血氧仪、新生儿听力筛检仪器和其他仪器。

从技术面来看，亚太新生儿筛检市场分为串联质谱（TMS）、分子检测、免疫检测和酵素检测、脉搏血氧筛检技术等技术。 2022 年，脉搏血氧仪筛检技术领域占据亚太地区最大的新生儿筛检市场。

根据测试类型，亚太新生儿筛检市场分为干血斑测试、听力筛检测试、危重先天性心臟病（CCHD）测试和其他测试类型。 2022 年，干血斑检测领域占据亚太地区最大的新生儿筛检市场。

依最终用户划分，亚太地区新生儿筛检市场分为医院、诊所和诊断实验室。到 2022 年，医院和诊所细分市场将占据更大的亚太新生儿筛检市场。

按国家/地区划分，亚太地区新生儿筛检市场分为中国、日本、印度、澳洲、韩国和亚太其他地区。 2022年，中国在亚太新生儿筛检市场占据主导地位。

Bio-Rad Laboratories Inc、LifeCell International Pvt Ltd、Masimo Corp、Medtronic Plc、Natus Medical Inc、PerkinElmer Inc、Trivitron Healthcare Pvt Ltd 和 Waters Corp 是亚太新生儿筛检市场上的一些领先公司。

目录

表中的内容

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区新生儿筛检市场 - 主要产业动态

  • 主要市场驱动因素
    • 政府为新生儿筛检提供的资金激增
    • 先天性疾病负担不断增加
    • 新生儿疾病盛行率不断增加
  • 主要市场限制
    • 新生儿筛检政策和实践缺乏统一
  • 主要市场机会
    • 新生儿基因筛检
  • 未来的趋势
    • 机器学习和人工智慧在筛检中的整合
  • 影响分析：

第 5 章：新生儿筛检市场 - 亚太市场分析

  • 2022 - 2030 年亚太地区新生儿筛检市场收入

第 6 章：亚太地区新生儿筛检市场 - 2030 年收入和预测 - 按产品类型

  • 概述
  • 2022 年及 2030 年亚太地区新生儿筛检市场收入份额（按产品类型划分）（%）
  • 试剂和检测试剂盒
  • 仪器

第 7 章：亚太地区新生儿筛检市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年及 2030 年亚太地区新生儿筛检市场收入份额（按技术划分）（%）
  • 串联质谱 (TMS)
  • 分子检测
  • 免疫测定和酵素测定
  • 脉搏血氧筛检技术
  • 其他技术

第 8 章：亚太地区新生儿筛检市场 - 2030 年收入和预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年亚太地区新生儿筛检市场收入份额，按测试类型划分 (%)
  • 干血斑测试
  • 听力筛检测试
  • 严重先天性心臟病 (CCHD) 测试
  • 其他测试类型

第 9 章：亚太地区新生儿筛检市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年亚太地区新生儿筛检市场收入份额（按最终用户划分）（%）
  • 医院和诊所
  • 诊断实验室

第 10 章：亚太地区新生儿筛检市场 - 国家分析

  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区

第 11 章：亚太地区新生儿筛检市场-产业格局

  • 概述
  • 新生儿筛检市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • LifeCell International Pvt Ltd
  • Trivitron Healthcare Pvt Ltd
  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • Medtronic Plc

第 13 章：附录

Product Code: BMIRE00029605

The Asia Pacific newborn screening market was valued at US$ 270.13 million in 2022 and is expected to reach US$ 602.14 million by 2030; it is estimated to grow at a CAGR of 10.5% from 2022 to 2030.

Genetic Screening of Newborns Fuels the Asia Pacific Newborn Screening Market.

The demand for comprehensive genetic screening of newborns is rising with the deepening knowledge about the genetic causes of medical conditions and advancements in healthcare technologies. As a result, companies in the newborn screening market are developing innovative, cost-effective screening solutions. Yescarta and Zynteglo are two examples of authorized gene treatments for large B-cell lymphoma and beta-thalassemia. Further, the emergence of technologies conferring an ability to identify genetic predispositions to diseases at birth pave the way for personalized healthcare, aligning with the broader trend of precision medicine.

Screening for genetic diseases during pregnancy also focuses on the early detection of pregnancy-related problems. Next-generation sequencing aids in the prenatal screening of neonates with a sensitivity of above 95% for detecting aneuploidies (such as Down syndrome and Trisomy 21) or partial chromosomal abnormalities (duplications or deletions) in all chromosomes. Fluorescence in-situ hybridization (FISH) is employed to detect monogenic illnesses such as sickle cell anemia; it also aids in an effective preimplantation genetic diagnosis. Noninvasive procedures such as the cell-free fetal DNA approach using maternal plasma are the recent advancements in genetic tests. The embryonic DNA can be distinguished from maternal DNA pieces based on differences in their sizes. Real-time PCR with fluorescent probes, shotgun sequencing (Solexa or Illumina), or huge targeted parallel sequencing can be used to examine DNA associated with fetal medical conditions. This would allow doctors to provide early molecular interventions with certain pharmacological therapies (pharmacogenetics) and to transform cells, tissues, and organs physically and chemically if this type of genetic screening is further researched. Thus, advancements in methods for screening infants for genetic disorders hold immense potential for the overall newborn screening market.

Asia Pacific Newborn Screening Market Overview

The newborn screening market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The Asia -Pacific newborn screening market is segmented into Japan, China, India, South Korea, Australia, and the Rest of Asia -Pacific. Asia -Pacific is expected to be the fastest-growing region in the global newborn screening market during 2022-2030. The projected growth of the market in this region can be associated with the high number of newborn births, the soaring prevalence of congenital diseases, rising awareness regarding early diagnosis of birth defects in newborns, and the presence of organizations working toward offering better solutions for newborn screening.

Screening of newborns in Asia -Pacific is gaining traction; government agencies in China, India, and other countries need to implement newborn screening programs owing to the high birth rate. According to the United Nations International Children's Emergency Fund (UNICEF), 67,385 babies are born in India each day, accounting for one-sixth of childbirths recorded globally in a day. In addition, India has become the most populated nation; as per Worldmapper, ~23 million babies were born in 2022, followed by China with the birth of 10 million babies. With the constantly soaring birth rate, the focus on infant care is increasing in India, as well as in other countries in Asia -Pacific.

Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Newborn Screening Market Segmentation

The Asia Pacific newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the Asia Pacific newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger Asia Pacific newborn screening market share in 2022. The reagents and assay kits segment is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the Asia Pacific newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest Asia Pacific newborn screening market share in 2022.

Based on test type, the Asia Pacific newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest Asia Pacific newborn screening market share in 2022.

By end user, the Asia Pacific newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger Asia Pacific newborn screening market share in 2022.

Based on country, the Asia Pacific newborn screening market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific newborn screening market in 2022.

Bio-Rad Laboratories Inc, LifeCell International Pvt Ltd, Masimo Corp, Medtronic Plc, Natus Medical Inc, PerkinElmer Inc, Trivitron Healthcare Pvt Ltd, and Waters Corp are some of the leading companies operating in the Asia Pacific newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 Asia Pacific Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Asia Pacific Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 Asia Pacific Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 Asia Pacific Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 Asia Pacific Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Newborn Screening Market - Country Analysis

  • 10.1 Asia Pacific Newborn Screening Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Newborn Screening Market, by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.2 China: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.2.1 China: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.2.2 China: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.1.3 China: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.1.4 China: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.1.5 China: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.2 Japan: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.2.1 Japan: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.2.2 Japan: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.2.3 Japan: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.2.4 Japan: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.2.5 Japan: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.3 India
        • 10.1.2.3.1 India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.2 India: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.2.1 India: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.2.2 India: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.3.3 India: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.3.4 India: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.3.5 India: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.2 Australia: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.2.1 Australia: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.2.2 Australia: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.4.3 Australia: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.4.4 Australia: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.4.5 Australia: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.2 South Korea: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.2.1 South Korea: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.2.2 South Korea: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.5.3 South Korea: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.5.4 South Korea: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.5.5 South Korea: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.2 Rest of Asia Pacific: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.2.1 Rest of Asia Pacific: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.2.2 Rest of Asia Pacific: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.2.6.3 Rest of Asia Pacific: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.2.6.4 Rest of Asia Pacific: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.2.6.5 Rest of Asia Pacific: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. Asia Pacific Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 LifeCell International Pvt Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Trivitron Healthcare Pvt Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 PerkinElmer Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Waters Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Bio-Rad Laboratories Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Masimo Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Natus Medical Inc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Medtronic Plc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Newborn Screening Market Segmentation
  • Table 2. Asia Pacific Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Asia Pacific Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. China Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. China Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. China Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. China Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Japan Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Japan Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Japan Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Japan Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Japan Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Japan Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. India Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. India Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. India Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. India Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. India Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. India Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Australia Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Australia Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Australia Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Australia Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Australia Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Australia Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. South Korea Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. South Korea Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. South Korea Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 | (US$ Million)
  • Table 31. South Korea Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. South Korea Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. South Korea Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Asia Pacific Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Asia Pacific Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Asia Pacific Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Asia Pacific Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Rest of Asia Pacific Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Rest of Asia Pacific Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 41. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 42. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. Asia Pacific Newborn Screening Market Segmentation, By Country
  • Figure 2. Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Asia Pacific Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Asia Pacific Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: Asia Pacific Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Asia Pacific Newborn Screening Market, by Key Country - Revenue, 2022 (US$ Million)
  • Figure 23. Asia Pacific Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. China Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Japan Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. India Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Australia Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. South Korea Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Rest of Asia Pacific Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Growth Strategies in Newborn Screening Market